Moderator: Bonnie Kirschenbaum, Consultant and Columnist
Panelists: Allen Broome, Assistant VP Pharmacy Services, Erlanger Health System and Melissa Duke, Senior Director, Ambulatory Pharmacy Services, Banner Health
It is imperative to stay focused on strategic, longer range initiatives as you lead your IDN pharmacy operations. Some of these issues that will continue to have impact are: buy and bill versus incorporating specialty pharmacy decisions; how are your reviewing new models that incorporate more partnerships with payors as well as the manufactures; managing more varied locations and working with the patient mix for each location; protecting against illicit drug use including more regulations on opioids; among many other topics we’ll explore in this strategic discussion on IDN pharmacy operations.
1. Compare different issues impacting IDN pharmacies and decide where you need to focus.
2. Assemble information on issues that you believe will impact your operations in 2020.
3. Describe the impact of non-action if your IDN doesn’t react to upcoming events.